These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31627301)

  • 1. Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives.
    Hong SS; Oh KT; Choi HG; Lim SJ
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31627301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations.
    Koo J; Lim C; Oh KT
    Int J Nanomedicine; 2024; 19():1767-1807. PubMed ID: 38414526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery.
    Duong VA; Nguyen TT; Maeng HJ
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System.
    Pandey M; Jain N; Kanoujia J; Hussain Z; Gorain B
    Front Pharmacol; 2022; 13():865590. PubMed ID: 35401164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease.
    Arora D; Bhatt S; Kumar M; Vattikonda HDC; Taneja Y; Jain V; Joshi V; Gali CC
    Curr Pharm Des; 2020; 26(27):3281-3299. PubMed ID: 32228421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.
    Babu SR; Shekara HH; Sahoo AK; Harsha Vardhan PV; Thiruppathi N; Venkatesh MP
    Ther Deliv; 2023 Sep; 14(9):571-594. PubMed ID: 37691577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Patent Review on Nanotechnology-Based Nose-to-Brain Drug Delivery.
    Singh R; Brumlik C; Vaidya M; Choudhury A
    Recent Pat Nanotechnol; 2020; 14(3):174-192. PubMed ID: 32384043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding Drug Delivery to the Brain Using Liposome-Based Strategies: Studies that Provide Mechanistic Insights Are Essential.
    Juhairiyah F; de Lange ECM
    AAPS J; 2021 Oct; 23(6):114. PubMed ID: 34713363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of drug delivery to the brain via nasal route.
    Kozlovskaya L; Abou-Kaoud M; Stepensky D
    J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hypotonic Environmental Changes Affect Liposomal Formulations for Nose-to-Brain Targeted Drug Delivery.
    Wu IY; Nikolaisen TE; Škalko-Basnet N; di Cagno MP
    J Pharm Sci; 2019 Aug; 108(8):2570-2579. PubMed ID: 30885660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration.
    Wei H; Liu T; Jiang N; Zhou K; Yang K; Ning W; Yu Y
    J Biomed Nanotechnol; 2018 Jul; 14(7):1252-1262. PubMed ID: 29944099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Lomustine and
    Katona G; Sabir F; Sipos B; Naveed M; Schelz Z; Zupkó I; Csóka I
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery systems from nose to brain.
    Misra A; Kher G
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle transport across in vitro olfactory cell monolayers.
    Gartziandia O; Egusquiaguirre SP; Bianco J; Pedraz JL; Igartua M; Hernandez RM; Préat V; Beloqui A
    Int J Pharm; 2016 Feb; 499(1-2):81-89. PubMed ID: 26721725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in brain targeting drug delivery system by nasal route.
    Khan AR; Liu M; Khan MW; Zhai G
    J Control Release; 2017 Dec; 268():364-389. PubMed ID: 28887135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development.
    Wen MM
    Discov Med; 2011 Jun; 11(61):497-503. PubMed ID: 21712015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.